ChartRow logo
Share this page
RYTM
$86.17-2.05%
as of close, Oct 16, 2026
☾ AH $86.17 -2.05%
PeersMRNALLYMDTUNHJNJTMO

Rhythm Pharmaceuticals Inc. trailing returns

How Rhythm Pharmaceuticals Inc. (RYTM) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-2.0%+0.0%-2.0%—
5 days-5.1%+0.0%-5.1%-5.1%Oct 16
1 month-12.1%+0.0%-12.1%-13.2%Oct 16
YTD-19.5%+0.0%-19.5%-33.1%Mar 27
1 year-22.5%+0.0%-22.5%-35.5%Mar 2026
5 years+50.1%+0.0%+50.1%+661.9%-77.6%May 2022
Since inception (2017)+14.9%+0.0%+14.9%+250.7%-92.1%May 2022

Growth of RYTM#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+50.1%/year · +661.9%
  • Since inception (2017)+14.9%/year · +250.7%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in RYTM's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Rhythm Pharmaceuticals Inc.'s return since inception?
Since 2017, Rhythm Pharmaceuticals Inc. (RYTM) has compounded at about +14.9% a year — +250.7% in total.

More on Rhythm Pharmaceuticals Inc.